V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20164293 | 20063179 | 1.8 | 69 | Adjuvant (A) | 2019-11-15 | 2019-12-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101450484 |
| 20164294 | 20063180 | 1.77 | 75.5 | Palliative (P) | 2018-02-04 | 2018-02-08 | ECX | N | N | ECX | 101072173 |
| 20164299 | 20063181 | 1.6 | 88 | 01 | 2016-03-30 | 2016-04-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100675276 |
| 20164304 | 20063182 | 1.64 | 58.6 | Adjuvant (A) | 2017-08-01 | 2017-08-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100788464 |
| 20164317 | 20063183 | 1.69 | 60.7 | Neo-adjuvant (N) | 2018-05-04 | 2018-05-04 | ECX | 2 | N | ECX | 100027359 |
| 20164323 | 20063184 | 1.61 | 82.2 | Palliative (P) | 2018-05-20 | 2018-06-09 | ECX | N | N | ECX | 101839514 |
| 20164325 | 20063185 | 1.64 | 89.5 | 03 | 2017-11-12 | 2017-11-19 | Gemcitabine + Capecitabine | Y | null | CAPECITABINE + GEMCITABINE | 101339167 |
| 20164327 | 20063186 | 1.7 | 69.1 | Adjuvant (A) | 2018-05-24 | 2018-06-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101311108 |
| 20164328 | 20063187 | 1.5 | 87 | Adjuvant (A) | 2018-09-05 | 2018-09-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100452232 |
| 20164333 | 20063188 | 1.54 | 93.2 | Neo-adjuvant (N) | 2020-01-05 | 2020-01-05 | ECX | N | N | ECX | 100668004 |
| 20164334 | 20063189 | 1.81 | 76 | Adjuvant (A) | 2016-12-15 | 2016-12-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101179056 |
| 20164336 | 20063190 | 1.52 | 51.2 | Neo-adjuvant (N) | 2016-03-26 | 2016-03-31 | ECX | 2 | N | ECX | 101712263 |
| 20164341 | 20063191 | 1.75 | 89 | Curative (C) | 2018-08-09 | 2018-08-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101019475 |
| 20164345 | 20063192 | null | null | Neo-adjuvant (N) | 2019-04-10 | 2019-04-23 | ECX | 02 | N | ECX | 101153873 |
| 20164349 | 20063193 | 1.67 | 101 | Adjuvant (A) | 2016-05-30 | 2016-05-31 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100523304 |
| 20164352 | 20063194 | 1.75 | 72.35 | Palliative (P) | 2019-10-15 | 2019-10-23 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100566145 |
| 20164359 | 20063195 | 1.72 | 81 | Curative (C) | 2016-02-15 | 2016-03-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101508780 |
| 20164360 | 20063196 | 1.82 | 64.8 | Adjuvant (A) | 2017-06-17 | 2017-07-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100629766 |
| 20164367 | 20063197 | 1.79 | 107 | Neo-adjuvant (N) | 2019-09-07 | 2019-09-15 | ECX | N | Y | ECX | 100171508 |
| 20164370 | 20063198 | 1.7 | 67 | Palliative (P) | 2016-08-06 | 2016-08-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100015900 |
| 20164382 | 20063199 | 1.7 | 52 | Palliative (P) | 2018-09-21 | 2018-09-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100347614 |
| 20164386 | 20063200 | 1.55 | 60.8 | Palliative (P) | 2018-11-21 | 2018-11-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100142394 |
| 20164388 | 20063201 | 1.72 | 66.9 | Adjuvant (A) | 2019-04-07 | 2019-04-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100698269 |
| 20164393 | 20063202 | 1.66 | 63.6 | Neo-adjuvant (N) | 2018-10-06 | 2018-11-11 | ECX | N | N | ECX | 101753831 |
| 20164394 | 20063203 | 1.52 | 49 | Neo-adjuvant (N) | 2018-10-28 | 2018-11-03 | ECX | N | null | ECX | 100694547 |
| 20164396 | 20063204 | 1.71 | 85.6 | null | 2016-04-15 | 2016-04-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101622509 |
| 20164403 | 20063205 | 1.52 | 67.7 | Neo-adjuvant (N) | 2019-10-25 | 2019-11-02 | ECX | N | N | ECX | 101152695 |
| 20164404 | 20063206 | 1.7 | 73.7 | Adjuvant (A) | 2018-11-24 | 2018-12-15 | ECX | N | N | ECX | 100441030 |
| 20164405 | 20063207 | 1.8 | 93 | Palliative (P) | 2017-12-02 | 2017-12-02 | ECX | 2 | N | ECX | 100624980 |
| 20164406 | 20063208 | 1.6 | 93.7 | null | 2018-10-10 | 2018-10-20 | ECX | N | N | ECX | 101569907 |
| 20164409 | 20063209 | 1.68 | 71.35 | Curative (C) | 2019-08-09 | 2019-08-22 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101584719 |
| 20164414 | 20063210 | 1.5 | 85.7 | Palliative (P) | 2016-04-24 | 2016-05-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101293218 |
| 20164420 | 20063211 | 1.64 | 76.9 | Adjuvant (A) | 2018-07-14 | 2018-07-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101164093 |
| 20164421 | 20063212 | 1.75 | 100 | Palliative (P) | 2016-12-15 | 2016-12-15 | ECX | 2 | N | ECX | 100237133 |
| 20164422 | 20063213 | 1.77 | 82.2 | Palliative (P) | null | 2018-02-22 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 100106600 |
| 20164423 | 20063214 | 1.69 | 61.7 | Adjuvant (A) | 2017-02-13 | 2017-02-21 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101561120 |
| 20164427 | 20063215 | 1.5 | 85.1 | Neo-adjuvant (N) | 2019-12-06 | 2019-12-17 | ECX | 02 | N | ECX | 100372003 |
| 20164430 | 20063216 | 1.74 | 77.3 | Palliative (P) | 2018-11-25 | 2018-12-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100313448 |
| 20164439 | 20063217 | 1.79 | 61 | Neo-adjuvant (N) | 2019-02-02 | 2019-02-08 | ECX | N | N | ECX | 100496174 |
| 20164450 | 20063218 | 1.72 | 69.5 | Palliative (P) | 2019-04-19 | 2019-05-02 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100880625 |
| 20164458 | 20063219 | 1.8 | 98.8 | Palliative (P) | 2020-01-12 | 2020-01-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100065872 |
| 20164460 | 20063220 | 1.77 | 82.6 | Palliative (P) | 2018-04-17 | 2018-05-06 | ECX | 02 | null | ECX | 101167305 |
| 20164466 | 20063221 | 1.82 | 80.7 | null | 2016-11-11 | 2016-11-11 | ECX | null | N | CAPECITABINE + GEMCITABINE | 101657744 |
| 20164469 | 20063222 | 1.75 | 88.9 | Palliative (P) | 2017-10-04 | 2017-10-04 | ECX | N | N | ECX | 101188338 |
| 20164471 | 20063223 | 1.6 | 82 | Curative (C) | 2019-06-28 | 2019-06-29 | ECX | null | N | ECX | 101868381 |
| 20164482 | 20063224 | 1.54 | 46 | Adjuvant (A) | 2016-03-05 | 2016-03-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100853223 |
| 20164485 | 20063225 | null | null | Neo-adjuvant (N) | 2018-09-15 | 2018-09-29 | ECX | N | N | ECX | 101712027 |
| 20164495 | 20063226 | 1.61 | 75 | Palliative (P) | 2018-12-09 | 2018-12-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100754737 |
| 20164497 | 20063227 | 1.76 | 92.8 | Palliative (P) | 2018-08-04 | 2018-08-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101489368 |
| 20164499 | 20063228 | 1.81 | 78 | Palliative (P) | 2017-01-15 | 2017-01-18 | ECX | N | N | ECX | 100210779 |